Magenta Therapeutics (MGTA) PT Lowered to $3 at BTIG
Tweet Send to a Friend
BTIG analyst Yun Zhong lowered the price target on Magenta Therapeutics (NASDAQ: MGTA) to $3.00 (from $6.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
